University of California San Diego

Cholesterol test
#Cholesterol #Drug development #Heart disease #University of California San Diego

Hidden pathway could be targeted to reduce heart disease 

A hidden biological pathway could be targeted to reduce cholesterol-related heart disease, research shows.  A team from the University of California San Diego School of Medicine uncovered a biological pathway involving the liver, explaining why high-cholesterol diets impede the body’s ability to clear harmful low-density lipoprotein (LDL)… Read More

#News

Patient using a mammography machine
#Breast cancer #Tumour biology #University of California San Diego

Discovery sheds light on new way to treat breast cancer 

A new discovery into how breast cancer spreads could pave the way for a new treatment.  Researchers at the University of California San Diego found an inflammatory protein, TYK2, is involved in the process by which cells sense and respond to their physical environment, known as mechanotransduction.  … Read More

#Cancer Research #News

#Awards #FDA #University of California San Diego

CIRM awards $7.4m for novel Freidreich’s ataxia therapy 

The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a first-of-its-kind stem cell-based gene therapy for Friedreich’s ataxia.  The funding, awarded to a team at the University of California San Diego, will help researchers complete the final steps required by federal regulators before they… Read More

#News

#ALS #Antibody drug conjugate (ADC) #Breast cancer #Cancer research #DDW Turning Science into Business Symposium #Gene therapy #Hunter Syndrome #Neurodegenerative disorders #Oncology #The University of Manchester #University of California San Diego

This week in Drug Discovery (24 – 28 November) 

News round-up for 24 – 28 November by Bruno Quinney, Content Team at DDW.  This week in drug discovery, gene therapies are providing solutions for complex conditions, most notably in Hunter syndrome but also in amyotrophic lateral sclerosis. Elsewhere, an antibody-drug conjugate precision therapy could prevent breast cancer. … Read More

#News

Cancer cells
#Antibody drug conjugate (ADC) #Breast cancer #University of California San Diego

ADC precision therapy could prevent breast cancer, study shows 

New research has identified a precision therapy which could stop breast cancer at the source.  Researchers at the University of California San Diego School of Medicine used an antibody-drug conjugate (ADC) to target a cell-surface protein known as FZD7. FZD7 is present on cells with high tumour-initiating potential in… Read More

#Cancer Research #News

Children excerising
#Ageing #Multiple sclerosis #Paediatrics #University of California San Diego

Evidence suggests accelerated ageing in children with MS

Researchers from University of California San Diego School of Medicine have discovered that children living with multiple sclerosis (MS) show signs of accelerated biological ageing, even in their teenage years.   The research published in Neurology, the medical journal of the American Academy of Neurology, is… Read More

#News

Neurones in the brain
#Alzheimer's #Cell and gene therapy #Cognitive impairment #Gene therapy #Neurology #Neuroscience #University of California San Diego

Alzheimer’s gene therapy shows promise in preserving brain function

Researchers at University of California San Diego School of Medicine have developed a gene therapy for Alzheimer’s disease (AD) that could help protect the brain from damage and preserve cognitive function. Unlike existing treatments for AD that target unhealthy protein deposits in the brain, the new approach could help address… Read More

#News

T cell attacking Covid-19
#Anti-virals #Covid-19 #Hyundai Bioscience #Long Covid #University of California San Diego

Hyundai Bioscience investigates antiviral for long Covid in US trial

Hyundai Bioscience USA and the University of California San Diego (UCSD) have agreed to conduct a clinical trial to evaluate the efficacy of Xafty, a niclosamide-based antiviral, in treating long Covid. “This is an outstanding opportunity for UCSD  and Hyundai Bioscience to partner together to tackle… Read More

#News